Cargando…

Validation of the prophylactic efficacy of urea‐based creams on sorafenib‐induced hand‐foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study

BACKGROUND: Hand‐foot skin reaction may influence the effectiveness of patients' treatment, patient quality of life, and the economics of health care. An effective prophylactic dermatological cream for preventing sorafenib‐induced hand‐foot skin reaction (HFSR) is yet to be identified. AIM: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lien, Ru‐Yu, Tung, Heng‐Hsin, Wu, Shang‐Laing, Hu, Sophia H., Lu, Ling‐Chun, Lu, Shu‐Fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327657/ https://www.ncbi.nlm.nih.gov/pubmed/34910380 http://dx.doi.org/10.1002/cnr2.1532

Ejemplares similares

The Use of Urea Cream for Hand Eczema and Urea Foam for Seborrheic Dermatitis and Psoriasiform Dermatoses of the Scalp
por: Celleno, Leonardo, et al.
Publicado: (2022)

Determination of urea content in urea cream by centrifugal partition chromatography
por: Wang, Ying-Qun, et al.
Publicado: (2016)

Grade III hand-foot skin reaction induced by sorafenib
por: Chiriac, Anca, et al.
Publicado: (2017)

Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol
por: Demirkan, Serkan, et al.
Publicado: (2017)

Sorafenib Induced Hand-Foot Skin Reaction at Low Dose
por: Shah, Vrutika H., et al.
Publicado: (2020)

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates
por: Ott, Patrick A., et al.
Publicado: (2010)

A Clinical Investigation of the Performance and Safety of Epaderm(®), an Emollient Cream
por: August, Suzannah, et al.
Publicado: (2021)

Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma
por: Sil, Amrita, et al.
Publicado: (2014)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
por: Kamimura, Kenya, et al.
Publicado: (2018)

10% urea cream in senile xerosis: Clinical and instrumental evaluation
por: Lacarrubba, Francesco, et al.
Publicado: (2021)

Interleukin 2 Topical Cream for Treatment of Diabetic Foot Ulcer: Experiment Protocol
por: Chan, Shu Wing Sophia
Publicado: (2015)

Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment
por: Ochi, Masanori, et al.
Publicado: (2021)

Plectranthus amboinicus and Centella asiatica Cream for the Treatment of Diabetic Foot Ulcers
por: Kuo, Yuan-Sung, et al.
Publicado: (2012)

Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
por: Shahda, Safi, et al.
Publicado: (2016)

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND)
por: Kwakkenbos, Linda, et al.
Publicado: (2022)

Effect of topical treatment with 7.5% urea in Ichthyosis Vulgaris: A randomized, controlled, double blinded, split body study evaluating the effect of urea cream compared to the vehicle (moisturizing) cream
por: Dorf, I. L. H., et al.
Publicado: (2021)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin
por: Ahmad Nasrollahi, Saman, et al.
Publicado: (2019)

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma
por: Uldrick, Thomas S., et al.
Publicado: (2017)

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
por: Dranitsaris, G., et al.
Publicado: (2012)

Antiaging efficacy of melatonin-based day and night creams: a randomized, split-face, assessor-blinded proof-of-concept trial
por: Milani, Massimo, et al.
Publicado: (2018)

Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20
por: Patt, Yehuda, et al.
Publicado: (2017)

Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
por: Abou‐Alfa, Ghassan K., et al.
Publicado: (2017)

Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II Study (DGA Study)
por: Yamamoto, Kazuhiro, et al.
Publicado: (2022)

Promoting public awareness of randomised clinical trials using the media: the ‘Get Randomised’ campaign
por: Mackenzie, Isla S, et al.
Publicado: (2010)

Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH)
por: Ostwal, Vikas, et al.
Publicado: (2022)

Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report
por: Velandia-Carrillo, Carlos, et al.
Publicado: (2014)

Reduced anterior cingulate grey matter volume in painful hand osteoarthritis
por: Russell, Mark D., et al.
Publicado: (2018)

Safety and Activity of Sorafenib in Addition to Vinflunine in Post‐Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial
por: Shah, Carl‐Henrik, et al.
Publicado: (2018)

Repeated hands-and-knees positioning during labour: a randomized pilot study
por: Hodnett, Ellen D., et al.
Publicado: (2013)

Evaluation of changes to foot shape in females 5 years after mastectomy: a case–control study
por: Głowacka-Mrotek, Iwona, et al.
Publicado: (2017)

Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study
por: Labeur, Tim A., et al.
Publicado: (2019)

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
por: Halpern, Anna B., et al.
Publicado: (2023)

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial
por: Gernsheimer, Terry B., et al.
Publicado: (2022)

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib
por: Jain, Lokesh, et al.
Publicado: (2010)

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
por: Lencioni, R, et al.
Publicado: (2010)

Prophylactic postoperative condom sheet placement: A randomized clinical trial to test a new concept
por: Ahmadi Amoli, Hadi, et al.
Publicado: (2021)

Hydrocolloid dressing as a prophylactic use for hand–foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study
por: Zenda, Sadamoto, et al.
Publicado: (2020)

Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
por: Ocvirk, Janja
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f69an2j69do8f25nt42l556aas